AFLAC Incorporated found using ticker (AFL) now have 12 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The target price ranges between 80 and 57 with the average target price sitting at 71. Given that the stocks previous close was at 68.9 this now indicates there is a potential upside of 3.0%. The 50 day MA is 71.52 and the 200 day MA is 62.6. The market capitalisation for the company is $43,146m. Find out more information at: https://www.aflac.com
The potential market cap would be $44,461m based on the market concensus.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
